Biomatrica Announces Acquisition by Exact Sciences

Biomatrica, a leader in sample collection, is pleased to announce that it has been acquired by Exact Sciences Corp. (NASDAQ: EXAS). Biomatrica will operate as a wholly owned subsidiary and will continue to supply sample preservation technologies to other companies.

Biomatrica’s biomarker collection portfolio includes LBgard® (blood collection tube for capturing circulating free DNA and cells for cancer screening and non-invasive pre-natal testing (NIPT), RNAgard® (blood collection tube for capturing both RNA and DNA for gene expression analysis in a single tube, with true ambient transportation), and SalivaGard™ (a device for capturing DNA in saliva designed for high throughput processing with reduced contamination risk).

Biomatrica will continue to deploy its capabilities in Exact Sciences’ early cancer screening pipeline as well as with its expanding client base in diagnostics and consumer genomics.

Biomatrica will remain based in San Diego and terms of the deal are not being disclosed.

About the Author:

Nick Ecos
President and CEO since January, 2015 is an accomplished biotechnology executive with over 25 years of experience in leadership roles involving turnaround and high growth businesses, including his previous role as Vice President and General Manager, Licensing and Commercial Supply at Thermo Fisher Scientific (formerly Life Technologies), and previously as General Manager of several operating units, including the Dynal bead-based separations business in Oslo, Norway. He earned his MBA from Harvard Business School.

Leave A Comment

BIOMATRICA
5627 Oberlin Drive
Suite 120
San Diego, CA 92121
Tel: 858-550-0308
Fax: 858-678-0597
Email: orders@biomatrica.com